- Home
- SCNI vs SPGC Comparison
SCNI vs SPGC Comparison
Compare SCNI & SPGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- SPGC
- Stock Information
- Founded
- SCNI 2003
- SPGC 2018
- Country
- SCNI Israel
- SPGC United States
- Employees
- SCNI N/A
- SPGC N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- SPGC
- Sector
- SCNI Health Care
- SPGC
- Exchange
- SCNI Nasdaq
- SPGC Nasdaq
- Market Cap
- SCNI 2.8M
- SPGC 2.6M
- IPO Year
- SCNI N/A
- SPGC 2023
- Fundamental
- Price
- SCNI $3.52
- SPGC $0.66
- Analyst Decision
- SCNI
- SPGC
- Analyst Count
- SCNI 0
- SPGC 0
- Target Price
- SCNI N/A
- SPGC N/A
- AVG Volume (30 Days)
- SCNI 20.5K
- SPGC 22.4M
- Earning Date
- SCNI 11-22-2024
- SPGC 03-17-2025
- Dividend Yield
- SCNI N/A
- SPGC N/A
- EPS Growth
- SCNI N/A
- SPGC N/A
- EPS
- SCNI 8.20
- SPGC N/A
- Revenue
- SCNI $452,000.00
- SPGC $2,491,000.00
- Revenue This Year
- SCNI N/A
- SPGC $912.03
- Revenue Next Year
- SCNI N/A
- SPGC $49.80
- P/E Ratio
- SCNI $0.43
- SPGC N/A
- Revenue Growth
- SCNI N/A
- SPGC 840.00
- 52 Week Low
- SCNI $2.23
- SPGC $0.26
- 52 Week High
- SCNI $8.92
- SPGC $6.97
- Technical
- Relative Strength Index (RSI)
- SCNI 52.91
- SPGC 51.47
- Support Level
- SCNI $3.30
- SPGC $0.35
- Resistance Level
- SCNI $3.60
- SPGC $1.34
- Average True Range (ATR)
- SCNI 0.25
- SPGC 0.22
- MACD
- SCNI -0.01
- SPGC 0.03
- Stochastic Oscillator
- SCNI 44.05
- SPGC 31.57
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About SPGC Sacks Parente Golf Inc.
Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. It designs, manufactures, and sells technology-forward, golf equipment, which is comprised of putting instruments, golf shafts, golf grips, and related product groups. It designs its golf products to fit golfers of all skill levels, amateur and professional. Its business segments currently include, golf putting instruments, golf shafts, and golf related products.